Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ALKS 5461
ALKS 5461
Alkermes sees swift turnaround for rejected schizophrenia med as FDA accepts resubmission
Fierce Biotech
Tue, 12/29/20 - 10:51 am
Alkermes
ALKS 5461
ALKS 3831
FDA
drug manufacturing
schizophrenia
More data could be key for Alkermes after FDA panel vote
BioCentury
Sat, 11/3/18 - 03:59 pm
Alkermes
ALKS 5461
major depressive disorder
FDA
FDA Blasts Data, Trial Design For Alkermes Depression Drug
Xconomy
Tue, 10/30/18 - 11:34 am
FDA
Alkermes
ALKS 5461
clinical trials
major depressive disorder
A double date with destiny for Alkermes
EP Vantage
Fri, 10/5/18 - 12:06 pm
Alkermes
FDA
clinical trials
ALKS 5461
ALKS 3831
Why FDA News About Alkermes ALKS 5461 Studies Is Not A Complete Surprise
CP Wire
Mon, 04/2/18 - 09:37 am
Alkermes
FDA
ALKS 5461
clinical trials
Why FDA News About Alkermes ALKS 5461 Studies Is Not A Complete Surprise
Mon, 04/2/18 - 09:33 am
Alkermes
ALKS 5461
major depressive disorder
FDA Rejects Alkermes NDA for Major Depressive Disorder Drug ALKS 5461
CP Wire
Mon, 04/2/18 - 09:01 am
Alkermes
FDA
depression
major depressive disorder
ALKS 5461
Will third trial be the charm for Alkermes' depression drug?
Fierce Biotech
Tue, 08/22/17 - 12:04 am
Alkermes
clinical trials
ALKS 5461
major depressive disorder
CNBC interviews Alkermes CEO about antidepressant comeback
Thu, 10/27/16 - 04:08 pm
Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma
24/7 Wall St
Sat, 10/22/16 - 03:30 pm
Alkermes
depression
suicide
suicidal ideation
ALKS 5461
A Biotech's Depression Drug Returns From Dead, Setting Up Test For FDA
Forbes
Thu, 10/20/16 - 08:13 pm
biotech
FDA
Alkermes
clinical depression
ALKS 5461
antidepressants
Alkermes CEO, Richard Pops, On ALKS 5461 And Challenges In Developing New Drugs For Depression
Forbes
Tue, 02/9/16 - 09:28 am
Alkermes
Richard Pops
ALKS 5461
clinical depression
Alkermes' Pipeline Development Impresses, Key Updates Ahead
Yahoo/Reuters
Tue, 07/22/14 - 08:54 am
Alkermes
Invega Sustenna
ALKS 3831
aripiprazole lauroxil
ALKS 5461
Alkermes announces advances with its late-stage CNS pipeline
Yahoo/Fly on the Wall
Wed, 01/8/14 - 08:37 am
Alkermes
aripiprazole lauroxil
schizophrenia
ALKS 5461
major depressive disorder
Alkermes depression drug gets fast track status
Bloomberg/Businessweek
Fri, 10/11/13 - 08:53 am
Alkermes
fast track
ALKS 5461
antidepressants
major depressive disorder
Biotech Clinical Trials Update: CRIS, ALKS, CHTP
Seeking Alpha
Wed, 06/22/11 - 08:14 am
clinical trials
ALKS 5461
depression
Alkermes
Northera
Chelsea Therapeutics
Multimeric-001
flu vaccine